Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Julphar
Mallinckrodt
Chinese Patent Office
US Army
Teva
Moodys
AstraZeneca
Baxter
Cerilliant

Generated: October 19, 2017

DrugPatentWatch Database Preview

ZANTAC Drug Profile

« Back to Dashboard

What is the patent landscape for Zantac, and what generic Zantac alternatives are available?

Zantac is a drug marketed by Glaxo Grp Ltd, Teligent, Glaxosmithkline, and Sanofi Us. and is included in nine NDAs.

The generic ingredient in ZANTAC is ranitidine hydrochloride. There are forty-three drug master file entries for this compound. One hundred and forty-three suppliers are listed for this compound. Additional details are available on the ranitidine hydrochloride profile page.

Summary for Tradename: ZANTAC

US Patents:0
Applicants:4
NDAs:9
Suppliers / Packagers: see list2
Bulk Api Vendors: see list84
Clinical Trials: see list11
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ZANTAC at DailyMed

Pharmacology for Tradename: ZANTAC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxo Grp Ltd
ZANTAC
ranitidine hydrochloride
SYRUP;ORAL019675-001Dec 30, 1988AARXYesYes► Subscribe► Subscribe► Subscribe
Sanofi Us
ZANTAC 150
ranitidine hydrochloride
TABLET;ORAL021698-001Aug 31, 2004OTCYesYes► Subscribe► Subscribe► Subscribe
Glaxo Grp Ltd
ZANTAC 150
ranitidine hydrochloride
GRANULE, EFFERVESCENT;ORAL020251-002Mar 31, 1994DISCNNoNo► Subscribe► Subscribe► Subscribe
Sanofi Us
ZANTAC 75
ranitidine hydrochloride
TABLET;ORAL020520-001Dec 19, 1995OTCNoNo► Subscribe► Subscribe► Subscribe
Sanofi Us
ZANTAC 150
ranitidine hydrochloride
TABLET;ORAL021698-002Mar 13, 2007OTCYesNo► Subscribe► Subscribe► Subscribe
Teligent
ZANTAC IN PLASTIC CONTAINER
ranitidine hydrochloride
INJECTABLE;INJECTION019593-002Sep 27, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe
Teligent
ZANTAC
ranitidine hydrochloride
INJECTABLE;INJECTION019090-001Oct 19, 1984APRXYesYes► Subscribe► Subscribe► Subscribe
Glaxo Grp Ltd
ZANTAC 150
ranitidine hydrochloride
TABLET;ORAL018703-001Jun 9, 1983ABRXYesNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
ZANTAC 150
ranitidine hydrochloride
CAPSULE;ORAL020095-001Mar 8, 1994DISCNYesNo► Subscribe► Subscribe► Subscribe
Glaxo Grp Ltd
ZANTAC 150
ranitidine hydrochloride
TABLET, EFFERVESCENT;ORAL020251-001Mar 31, 1994DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ZANTAC

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teligent
ZANTAC
ranitidine hydrochloride
INJECTABLE;INJECTION019090-001Oct 19, 1984► Subscribe► Subscribe
Glaxo Grp Ltd
ZANTAC
ranitidine hydrochloride
SYRUP;ORAL019675-001Dec 30, 1988► Subscribe► Subscribe
Glaxo Grp Ltd
ZANTAC
ranitidine hydrochloride
SYRUP;ORAL019675-001Dec 30, 1988► Subscribe► Subscribe
Glaxo Grp Ltd
ZANTAC
ranitidine hydrochloride
SYRUP;ORAL019675-001Dec 30, 1988► Subscribe► Subscribe
Teligent
ZANTAC
ranitidine hydrochloride
INJECTABLE;INJECTION019090-001Oct 19, 1984► Subscribe► Subscribe
Glaxo Grp Ltd
ZANTAC
ranitidine hydrochloride
SYRUP;ORAL019675-001Dec 30, 1988► Subscribe► Subscribe
Teligent
ZANTAC
ranitidine hydrochloride
INJECTABLE;INJECTION019090-001Oct 19, 1984► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for ZANTAC

Drugname Dosage Strength RLD Submissiondate
ranitidine hydrochlorideTablets150 mgZantac 15010/30/2007
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Fish and Richardson
Chubb
Novartis
Boehringer Ingelheim
Healthtrust
Moodys
US Army
UBS
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot